SIRPA and multiple sclerosis: Thus, it may be useful to consider targeting SIRPα-CD47 interaction to accelerate the removal of myelin debris in Wallerian degeneration and additional pathologies of the nervous system in which myelin breaks down and impedes healing (e.g., multiple sclerosis).